

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vitamin A metabolic process (GO:0006776) | 8.36816790 |
| 2 | myelination in peripheral nervous system (GO:0022011) | 8.12148004 |
| 3 | peripheral nervous system axon ensheathment (GO:0032292) | 8.12148004 |
| 4 | ensheathment of neurons (GO:0007272) | 7.15639057 |
| 5 | axon ensheathment (GO:0008366) | 7.15639057 |
| 6 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 7.12755894 |
| 7 | myelin assembly (GO:0032288) | 6.28611467 |
| 8 | peripheral nervous system development (GO:0007422) | 6.00467041 |
| 9 | neurofilament cytoskeleton organization (GO:0060052) | 5.50382252 |
| 10 | hemidesmosome assembly (GO:0031581) | 5.42013965 |
| 11 | proline transport (GO:0015824) | 5.40459489 |
| 12 | myelination (GO:0042552) | 5.36449180 |
| 13 | regulation of pigment cell differentiation (GO:0050932) | 5.34125064 |
| 14 | positive regulation of neurological system process (GO:0031646) | 5.26504704 |
| 15 | regulation of apoptotic cell clearance (GO:2000425) | 5.16230895 |
| 16 | Leydig cell differentiation (GO:0033327) | 5.06285741 |
| 17 | regulation of complement activation (GO:0030449) | 4.84550566 |
| 18 | regulation of protein activation cascade (GO:2000257) | 4.84004728 |
| 19 | plasma lipoprotein particle assembly (GO:0034377) | 4.77333335 |
| 20 | male sex determination (GO:0030238) | 4.77268039 |
| 21 | cell adhesion mediated by integrin (GO:0033627) | 4.73598961 |
| 22 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.72514500 |
| 23 | low-density lipoprotein particle remodeling (GO:0034374) | 4.65003728 |
| 24 | myelin maintenance (GO:0043217) | 4.60020963 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 4.59748143 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.51419375 |
| 27 | protein-lipid complex assembly (GO:0065005) | 4.48230992 |
| 28 | positive regulation of developmental pigmentation (GO:0048087) | 4.42795055 |
| 29 | basement membrane organization (GO:0071711) | 4.41965133 |
| 30 | protein-chromophore linkage (GO:0018298) | 4.38784277 |
| 31 | detection of temperature stimulus (GO:0016048) | 4.31931015 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.21135177 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.18464591 |
| 34 | alanine transport (GO:0032328) | 4.17559277 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.06226173 |
| 36 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.87727141 |
| 37 | regulation of fibrinolysis (GO:0051917) | 3.71568639 |
| 38 | glycine transport (GO:0015816) | 3.65807905 |
| 39 | protein carboxylation (GO:0018214) | 3.60469027 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.60469027 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 3.60353564 |
| 42 | macromolecular complex remodeling (GO:0034367) | 3.60353564 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 3.60353564 |
| 44 | cholesterol efflux (GO:0033344) | 3.57068806 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 3.55783654 |
| 46 | cell migration in hindbrain (GO:0021535) | 3.52079723 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.48743963 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.48743963 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.48743963 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.48743963 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.48743963 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.48743963 |
| 53 | plasma lipoprotein particle organization (GO:0071827) | 3.47830125 |
| 54 | low-density lipoprotein particle clearance (GO:0034383) | 3.46915284 |
| 55 | regulation of lipoprotein metabolic process (GO:0050746) | 3.45599757 |
| 56 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.45382935 |
| 57 | collagen fibril organization (GO:0030199) | 3.44496815 |
| 58 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.41514555 |
| 59 | melanin biosynthetic process (GO:0042438) | 3.41019892 |
| 60 | protein-lipid complex subunit organization (GO:0071825) | 3.39804799 |
| 61 | extracellular fibril organization (GO:0043206) | 3.38470613 |
| 62 | cranial nerve structural organization (GO:0021604) | 3.37905499 |
| 63 | detection of external biotic stimulus (GO:0098581) | 3.37071827 |
| 64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.36604935 |
| 65 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.35958144 |
| 66 | layer formation in cerebral cortex (GO:0021819) | 3.34984941 |
| 67 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.34553649 |
| 68 | tyrosine metabolic process (GO:0006570) | 3.28978003 |
| 69 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27788143 |
| 70 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27788143 |
| 71 | melanin metabolic process (GO:0006582) | 3.25238052 |
| 72 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.24809014 |
| 73 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.22874644 |
| 74 | phospholipid efflux (GO:0033700) | 3.22394029 |
| 75 | plasma membrane repair (GO:0001778) | 3.20917534 |
| 76 | collagen catabolic process (GO:0030574) | 3.20734901 |
| 77 | skin development (GO:0043588) | 3.20689831 |
| 78 | regulation of myelination (GO:0031641) | 3.19719366 |
| 79 | negative regulation of protein activation cascade (GO:2000258) | 3.19535354 |
| 80 | regulation of humoral immune response (GO:0002920) | 3.17600154 |
| 81 | hyaluronan metabolic process (GO:0030212) | 3.16666402 |
| 82 | glial cell proliferation (GO:0014009) | 3.16335455 |
| 83 | neuronal action potential (GO:0019228) | 3.15413219 |
| 84 | blood coagulation, intrinsic pathway (GO:0007597) | 3.14891386 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 3.14484019 |
| 86 | negative regulation of sterol transport (GO:0032372) | 3.14484019 |
| 87 | regulation of somitogenesis (GO:0014807) | 3.12417803 |
| 88 | neuronal ion channel clustering (GO:0045161) | 3.10944782 |
| 89 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09966500 |
| 90 | collagen metabolic process (GO:0032963) | 3.09330741 |
| 91 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.07828286 |
| 92 | pinocytosis (GO:0006907) | 3.04355938 |
| 93 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.03762261 |
| 94 | detection of biotic stimulus (GO:0009595) | 3.03365572 |
| 95 | acute-phase response (GO:0006953) | 3.02385034 |
| 96 | regulation of plasminogen activation (GO:0010755) | 3.00408794 |
| 97 | complement activation, classical pathway (GO:0006958) | 2.99031080 |
| 98 | positive regulation of extracellular matrix organization (GO:1903055) | 2.98720539 |
| 99 | enteric nervous system development (GO:0048484) | 2.97915672 |
| 100 | axon cargo transport (GO:0008088) | 2.96870098 |
| 101 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.95013976 |
| 102 | extracellular matrix disassembly (GO:0022617) | 2.94877554 |
| 103 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94843138 |
| 104 | positive regulation of phagocytosis (GO:0050766) | 2.93605882 |
| 105 | diacylglycerol metabolic process (GO:0046339) | 2.93117777 |
| 106 | multicellular organismal catabolic process (GO:0044243) | 2.92543631 |
| 107 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.91616405 |
| 108 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.91402163 |
| 109 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.91402163 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 2.90010524 |
| 111 | behavioral response to pain (GO:0048266) | 2.88360605 |
| 112 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.88232974 |
| 113 | detection of other organism (GO:0098543) | 2.87932789 |
| 114 | protein activation cascade (GO:0072376) | 2.86010357 |
| 115 | high-density lipoprotein particle remodeling (GO:0034375) | 2.85853025 |
| 116 | response to mercury ion (GO:0046689) | 2.83959229 |
| 117 | negative regulation of axonogenesis (GO:0050771) | 2.82793891 |
| 118 | mannose metabolic process (GO:0006013) | 2.82553349 |
| 119 | protein heterotrimerization (GO:0070208) | 2.82252685 |
| 120 | complement activation (GO:0006956) | 2.82028639 |
| 121 | semaphorin-plexin signaling pathway (GO:0071526) | 2.80872732 |
| 122 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.80465567 |
| 123 | protein targeting to plasma membrane (GO:0072661) | 2.79781147 |
| 124 | actin filament depolymerization (GO:0030042) | 2.79187057 |
| 125 | intestinal cholesterol absorption (GO:0030299) | 2.78848512 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78290976 |
| 127 | cellular extravasation (GO:0045123) | 2.77780504 |
| 128 | negative regulation of complement activation (GO:0045916) | 2.76923099 |
| 129 | multicellular organismal metabolic process (GO:0044236) | 2.76788683 |
| 130 | negative regulation of adherens junction organization (GO:1903392) | 2.76628496 |
| 131 | negative regulation of focal adhesion assembly (GO:0051895) | 2.76628496 |
| 132 | negative regulation of cell junction assembly (GO:1901889) | 2.76628496 |
| 133 | negative regulation of axon extension (GO:0030517) | 2.76625982 |
| 134 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.75799889 |
| 135 | cellular hyperosmotic response (GO:0071474) | 2.75216646 |
| 136 | cell-substrate junction assembly (GO:0007044) | 2.74812047 |
| 137 | anatomical structure arrangement (GO:0048532) | 2.74287390 |
| 138 | sodium ion export (GO:0071436) | 2.73170150 |
| 139 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.72893740 |
| 140 | fibril organization (GO:0097435) | 2.70262233 |
| 141 | renal system development (GO:0072001) | 2.70159347 |
| 142 | * cell-cell junction maintenance (GO:0045217) | 2.69944644 |
| 143 | endodermal cell differentiation (GO:0035987) | 2.69309424 |
| 144 | modified amino acid transport (GO:0072337) | 2.69265205 |
| 145 | membrane depolarization during action potential (GO:0086010) | 2.69095115 |
| 146 | L-phenylalanine catabolic process (GO:0006559) | 2.69024160 |
| 147 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.69024160 |
| 148 | secondary metabolite biosynthetic process (GO:0044550) | 2.68996354 |
| 149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.67841062 |
| 150 | response to peptidoglycan (GO:0032494) | 2.67345708 |
| 151 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.66906619 |
| 152 | neuron projection regeneration (GO:0031102) | 2.66830580 |
| 153 | fatty acid elongation (GO:0030497) | 2.66665410 |
| 154 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65089106 |
| 155 | cortical actin cytoskeleton organization (GO:0030866) | 2.64638735 |
| 156 | regulation of response to osmotic stress (GO:0047484) | 2.64382509 |
| 157 | detection of bacterium (GO:0016045) | 2.64280420 |
| 158 | cellular potassium ion homeostasis (GO:0030007) | 2.63717614 |
| 159 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.63556101 |
| 160 | detection of light stimulus involved in visual perception (GO:0050908) | 2.63556101 |
| 161 | cholesterol biosynthetic process (GO:0006695) | 2.61707990 |
| 162 | synaptic vesicle maturation (GO:0016188) | 2.61551727 |
| 163 | retinal metabolic process (GO:0042574) | 2.59107643 |
| 164 | regulation of cholesterol storage (GO:0010885) | 2.58821404 |
| 165 | macrophage activation involved in immune response (GO:0002281) | 2.58458678 |
| 166 | growth hormone receptor signaling pathway (GO:0060396) | 2.57593149 |
| 167 | response to muramyl dipeptide (GO:0032495) | 2.57400906 |
| 168 | actin filament capping (GO:0051693) | 2.57287573 |
| 169 | cell-matrix adhesion (GO:0007160) | 2.55552459 |
| 170 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.54900265 |
| 171 | reverse cholesterol transport (GO:0043691) | 2.51929673 |
| 172 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.49980817 |
| 173 | cellular response to electrical stimulus (GO:0071257) | 2.48429574 |
| 174 | regulation of phagocytosis (GO:0050764) | 2.48061760 |
| 175 | axon development (GO:0061564) | 2.47158686 |
| 176 | regulation of extracellular matrix organization (GO:1903053) | 2.46955895 |
| 177 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.46853149 |
| 178 | cell communication involved in cardiac conduction (GO:0086065) | 2.46499980 |
| 179 | regulation of extracellular matrix disassembly (GO:0010715) | 2.45988902 |
| 180 | nerve growth factor signaling pathway (GO:0038180) | 2.44352363 |
| 181 | positive regulation of Ras protein signal transduction (GO:0046579) | 2.43733161 |
| 182 | intermediate filament organization (GO:0045109) | 2.43426214 |
| 183 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.43202790 |
| 184 | response to pain (GO:0048265) | 2.40022236 |
| 185 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.40013006 |
| 186 | regulation of axon extension (GO:0030516) | 2.39162700 |
| 187 | negative regulation of actin filament depolymerization (GO:0030835) | 2.39011512 |
| 188 | regulation of axonogenesis (GO:0050770) | 2.36605490 |
| 189 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.36022760 |
| 190 | regulation of early endosome to late endosome transport (GO:2000641) | 2.35840789 |
| 191 | regulation of neuron migration (GO:2001222) | 2.35376351 |
| 192 | regulation of developmental pigmentation (GO:0048070) | 2.34185028 |
| 193 | positive regulation of small GTPase mediated signal transduction (GO:0051057) | 2.34064478 |
| 194 | sterol biosynthetic process (GO:0016126) | 2.32752695 |
| 195 | regulation of neurological system process (GO:0031644) | 2.31409667 |
| 196 | anatomical structure maturation (GO:0071695) | 2.31362721 |
| 197 | negative regulation of catenin import into nucleus (GO:0035414) | 2.30435703 |
| 198 | neuronal action potential propagation (GO:0019227) | 12.7820656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.97542705 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.10246563 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.47279527 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.85718632 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.79484262 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.77627506 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.70894714 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.68618285 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.66457836 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.58189694 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.57342324 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54828162 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48342193 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.38466170 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.32961915 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28606936 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.25451085 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.25419007 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.23362457 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10832156 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.04333814 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01537581 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01503839 |
| 24 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00260044 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.99162273 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98443720 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.97840953 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.97840953 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.94708233 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92595297 |
| 31 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88346471 |
| 32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.87700606 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.86096340 |
| 34 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.85694055 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85586339 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80933698 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78997700 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78576378 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68589814 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.68297004 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67739149 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66552576 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.66231398 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64808901 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64714158 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64041626 |
| 47 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63161239 |
| 48 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.62627229 |
| 49 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.60808412 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.59836830 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58610321 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56941373 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55146392 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.54579280 |
| 55 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.53533389 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.53266315 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53187917 |
| 58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52587807 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52053632 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49931765 |
| 61 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.49610098 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48614446 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.47718051 |
| 64 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46342205 |
| 65 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.45380379 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45209475 |
| 67 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.44905772 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43710768 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41744580 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.41421792 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39644331 |
| 72 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39474374 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38794426 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38777249 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.37954940 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.37502426 |
| 77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37276770 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35651916 |
| 79 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35266162 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35139479 |
| 81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34848269 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32451548 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32400256 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31977050 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31625063 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31378206 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30787898 |
| 88 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.30692416 |
| 89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30435175 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.30219466 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29908561 |
| 92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28895676 |
| 93 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28418987 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.27821378 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27555803 |
| 96 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26632224 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26341894 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25703499 |
| 99 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25351861 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24916624 |
| 101 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24589573 |
| 102 | P68_20966046_ChIP-Seq_HELA_Human | 1.24270363 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24144474 |
| 104 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22633776 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22539085 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22007527 |
| 107 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21556463 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21153120 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20920971 |
| 110 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20850736 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19314116 |
| 112 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18890713 |
| 113 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18737375 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18440841 |
| 115 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.18235264 |
| 116 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.17856155 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17427383 |
| 118 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14297437 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.14111225 |
| 120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12984562 |
| 121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12674265 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12304957 |
| 123 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11705340 |
| 124 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11199085 |
| 125 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11133824 |
| 126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.11078196 |
| 127 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11049327 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10111151 |
| 129 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09402293 |
| 130 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09150537 |
| 131 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08887572 |
| 132 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08366647 |
| 133 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06705849 |
| 134 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05522409 |
| 135 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.05462929 |
| 136 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04701399 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04527526 |
| 138 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04038990 |
| 139 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03648688 |
| 140 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03555318 |
| 141 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03482585 |
| 142 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03146647 |
| 143 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02862343 |
| 144 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02658650 |
| 145 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02029916 |
| 146 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01488770 |
| 147 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00969538 |
| 148 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00907840 |
| 149 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.00803779 |
| 150 | AR_19668381_ChIP-Seq_PC3_Human | 1.00376557 |
| 151 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99965041 |
| 152 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.98483703 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98355035 |
| 154 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97967084 |
| 155 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.97528760 |
| 156 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97247899 |
| 157 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97247899 |
| 158 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97016387 |
| 159 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96856714 |
| 160 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96786323 |
| 161 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96392176 |
| 162 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93993440 |
| 163 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93662657 |
| 164 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93248461 |
| 165 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93136229 |
| 166 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92652662 |
| 167 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92339513 |
| 168 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92158910 |
| 169 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90680095 |
| 170 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90606540 |
| 171 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89869695 |
| 172 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.89702365 |
| 173 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89196461 |
| 174 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88508739 |
| 175 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88145086 |
| 176 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.87558754 |
| 177 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87019564 |
| 178 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84875399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 8.86912321 |
| 2 | MP0001968_abnormal_touch/_nociception | 5.85253528 |
| 3 | MP0004272_abnormal_basement_membrane | 5.48235739 |
| 4 | MP0008260_abnormal_autophagy | 4.71248774 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.29651113 |
| 6 | * MP0000920_abnormal_myelination | 4.20658873 |
| 7 | MP0003136_yellow_coat_color | 3.97018056 |
| 8 | MP0003045_fibrosis | 3.60941459 |
| 9 | MP0004858_abnormal_nervous_system | 3.52071729 |
| 10 | MP0000751_myopathy | 3.37817147 |
| 11 | MP0000749_muscle_degeneration | 3.25669345 |
| 12 | MP0000747_muscle_weakness | 3.20275249 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 3.13271242 |
| 14 | MP0005623_abnormal_meninges_morphology | 2.90927249 |
| 15 | MP0002733_abnormal_thermal_nociception | 2.83003571 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.80432714 |
| 17 | MP0002736_abnormal_nociception_after | 2.78609603 |
| 18 | MP0005275_abnormal_skin_tensile | 2.77107724 |
| 19 | * MP0003634_abnormal_glial_cell | 2.72117230 |
| 20 | MP0005451_abnormal_body_composition | 2.61248874 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.44417586 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.42768330 |
| 23 | MP0004270_analgesia | 2.39149114 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 2.33294939 |
| 25 | MP0003436_decreased_susceptibility_to | 2.28595851 |
| 26 | MP0003315_abnormal_perineum_morphology | 2.24499734 |
| 27 | MP0003724_increased_susceptibility_to | 2.13829824 |
| 28 | MP0000013_abnormal_adipose_tissue | 2.11010097 |
| 29 | * MP0002272_abnormal_nervous_system | 2.05132399 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 2.04974441 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.94484797 |
| 32 | MP0003122_maternal_imprinting | 1.94439757 |
| 33 | MP0009840_abnormal_foam_cell | 1.90451327 |
| 34 | MP0001661_extended_life_span | 1.90001637 |
| 35 | MP0004381_abnormal_hair_follicle | 1.89511484 |
| 36 | MP0001970_abnormal_pain_threshold | 1.88639881 |
| 37 | MP0003632_abnormal_nervous_system | 1.87369544 |
| 38 | MP0001324_abnormal_eye_pigmentation | 1.83315422 |
| 39 | MP0003329_amyloid_beta_deposits | 1.80813967 |
| 40 | MP0002132_abnormal_respiratory_system | 1.80069437 |
| 41 | MP0008569_lethality_at_weaning | 1.75560016 |
| 42 | MP0005503_abnormal_tendon_morphology | 1.72599875 |
| 43 | * MP0002067_abnormal_sensory_capabilities | 1.72366339 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.70837376 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.61905677 |
| 46 | MP0005365_abnormal_bile_salt | 1.58816114 |
| 47 | MP0000371_diluted_coat_color | 1.55760592 |
| 48 | * MP0002419_abnormal_innate_immunity | 1.51399084 |
| 49 | MP0002075_abnormal_coat/hair_pigmentati | 1.49776766 |
| 50 | MP0000750_abnormal_muscle_regeneration | 1.49479521 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.47005436 |
| 52 | MP0002168_other_aberrant_phenotype | 1.43250991 |
| 53 | MP0009278_abnormal_bone_marrow | 1.43234997 |
| 54 | MP0002938_white_spotting | 1.41477410 |
| 55 | MP0005171_absent_coat_pigmentation | 1.40651146 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.38419654 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.37156879 |
| 58 | MP0004859_abnormal_synaptic_plasticity | 1.36696932 |
| 59 | MP0005670_abnormal_white_adipose | 1.36319605 |
| 60 | MP0000604_amyloidosis | 1.35164059 |
| 61 | MP0005253_abnormal_eye_physiology | 1.29165772 |
| 62 | MP0005025_abnormal_response_to | 1.27753233 |
| 63 | MP0001186_pigmentation_phenotype | 1.25390443 |
| 64 | MP0009046_muscle_twitch | 1.25302432 |
| 65 | MP0001915_intracranial_hemorrhage | 1.24774649 |
| 66 | MP0002933_joint_inflammation | 1.23590064 |
| 67 | MP0002108_abnormal_muscle_morphology | 1.23060281 |
| 68 | MP0000685_abnormal_immune_system | 1.18427981 |
| 69 | MP0003123_paternal_imprinting | 1.17568172 |
| 70 | MP0005360_urolithiasis | 1.17300914 |
| 71 | * MP0003631_nervous_system_phenotype | 1.16637974 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.13296032 |
| 73 | MP0002269_muscular_atrophy | 1.09666393 |
| 74 | MP0003075_altered_response_to | 1.09565411 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.07779602 |
| 76 | MP0004811_abnormal_neuron_physiology | 1.07320894 |
| 77 | MP0010771_integument_phenotype | 1.07151835 |
| 78 | MP0001790_abnormal_immune_system | 1.06898401 |
| 79 | MP0005387_immune_system_phenotype | 1.06898401 |
| 80 | MP0003950_abnormal_plasma_membrane | 1.06449289 |
| 81 | MP0000609_abnormal_liver_physiology | 1.06180308 |
| 82 | MP0009115_abnormal_fat_cell | 1.03954418 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 1.03924023 |
| 84 | MP0002751_abnormal_autonomic_nervous | 1.02172805 |
| 85 | MP0001348_abnormal_lacrimal_gland | 1.01323505 |
| 86 | MP0001299_abnormal_eye_distance/ | 1.00008077 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.99693693 |
| 88 | MP0001958_emphysema | 0.99141103 |
| 89 | MP0009785_altered_susceptibility_to | 0.96533019 |
| 90 | MP0005000_abnormal_immune_tolerance | 0.95356818 |
| 91 | MP0005083_abnormal_biliary_tract | 0.94036225 |
| 92 | MP0005410_abnormal_fertilization | 0.94003075 |
| 93 | MP0003828_pulmonary_edema | 0.93987499 |
| 94 | MP0006276_abnormal_autonomic_nervous | 0.93823138 |
| 95 | MP0000778_abnormal_nervous_system | 0.90819674 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.90358728 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.89686095 |
| 98 | MP0001800_abnormal_humoral_immune | 0.89089444 |
| 99 | MP0003635_abnormal_synaptic_transmissio | 0.87892895 |
| 100 | MP0005408_hypopigmentation | 0.87327919 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.86805662 |
| 102 | MP0004130_abnormal_muscle_cell | 0.86291931 |
| 103 | MP0003195_calcinosis | 0.85763955 |
| 104 | * MP0002723_abnormal_immune_serum | 0.83600900 |
| 105 | MP0002118_abnormal_lipid_homeostasis | 0.83454391 |
| 106 | MP0005377_hearing/vestibular/ear_phenot | 0.83163391 |
| 107 | MP0003878_abnormal_ear_physiology | 0.83163391 |
| 108 | MP0002396_abnormal_hematopoietic_system | 0.81916785 |
| 109 | MP0005085_abnormal_gallbladder_physiolo | 0.80683278 |
| 110 | MP0008469_abnormal_protein_level | 0.80609698 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.80228589 |
| 112 | MP0000462_abnormal_digestive_system | 0.79963119 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.78483766 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.78463448 |
| 115 | MP0002064_seizures | 0.78455739 |
| 116 | MP0002971_abnormal_brown_adipose | 0.78252560 |
| 117 | MP0003279_aneurysm | 0.77726645 |
| 118 | MP0005164_abnormal_response_to | 0.77554912 |
| 119 | MP0005409_darkened_coat_color | 0.77184791 |
| 120 | MP0002405_respiratory_system_inflammati | 0.76241529 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.74915243 |
| 122 | MP0004087_abnormal_muscle_fiber | 0.72534497 |
| 123 | MP0004883_abnormal_blood_vessel | 0.72192107 |
| 124 | MP0002184_abnormal_innervation | 0.71952527 |
| 125 | MP0000955_abnormal_spinal_cord | 0.71942154 |
| 126 | MP0000858_altered_metastatic_potential | 0.71830583 |
| 127 | * MP0002452_abnormal_antigen_presenting | 0.71557390 |
| 128 | MP0002106_abnormal_muscle_physiology | 0.71503570 |
| 129 | * MP0002420_abnormal_adaptive_immunity | 0.71221072 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.71218548 |
| 131 | MP0001835_abnormal_antigen_presentation | 0.70990088 |
| 132 | MP0000569_abnormal_digit_pigmentation | 0.70473321 |
| 133 | * MP0001819_abnormal_immune_cell | 0.69568009 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.69448163 |
| 135 | * MP0003633_abnormal_nervous_system | 0.68681091 |
| 136 | MP0005397_hematopoietic_system_phenotyp | 0.68314224 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.68314224 |
| 138 | MP0005551_abnormal_eye_electrophysiolog | 0.67134993 |
| 139 | MP0009384_cardiac_valve_regurgitation | 0.66533285 |
| 140 | MP0010234_abnormal_vibrissa_follicle | 0.66294235 |
| 141 | MP0004947_skin_inflammation | 0.65028120 |
| 142 | MP0005423_abnormal_somatic_nervous | 0.64725927 |
| 143 | MP0005391_vision/eye_phenotype | 0.64607637 |
| 144 | MP0003690_abnormal_glial_cell | 0.64528150 |
| 145 | MP0002837_dystrophic_cardiac_calcinosis | 0.64119777 |
| 146 | MP0004233_abnormal_muscle_weight | 0.63871832 |
| 147 | MP0001270_distended_abdomen | 0.63194107 |
| 148 | * MP0002229_neurodegeneration | 0.62895941 |
| 149 | * MP0002882_abnormal_neuron_morphology | 0.62862219 |
| 150 | * MP0002066_abnormal_motor_capabilities/c | 0.62238769 |
| 151 | MP0001845_abnormal_inflammatory_respons | 0.62211798 |
| 152 | MP0000678_abnormal_parathyroid_gland | 0.61431415 |
| 153 | MP0003303_peritoneal_inflammation | 0.60854384 |
| 154 | MP0005369_muscle_phenotype | 0.60590322 |
| 155 | MP0000534_abnormal_ureter_morphology | 0.60354649 |
| 156 | MP0002557_abnormal_social/conspecific_i | 0.58082953 |
| 157 | MP0000003_abnormal_adipose_tissue | 0.53452289 |
| 158 | MP0002060_abnormal_skin_morphology | 0.52619742 |
| 159 | MP0005330_cardiomyopathy | 0.51207119 |
| 160 | MP0004134_abnormal_chest_morphology | 0.48491955 |
| 161 | MP0003566_abnormal_cell_adhesion | 0.46565277 |
| 162 | MP0000759_abnormal_skeletal_muscle | 0.44607595 |
| 163 | MP0003283_abnormal_digestive_organ | 0.44533395 |
| 164 | MP0009780_abnormal_chondrocyte_physiolo | 0.44366342 |
| 165 | MP0005187_abnormal_penis_morphology | 0.43884051 |
| 166 | MP0003300_gastrointestinal_ulcer | 0.43546848 |
| 167 | MP0003091_abnormal_cell_migration | 0.42684322 |
| 168 | MP0002752_abnormal_somatic_nervous | 0.42356911 |
| 169 | MP0008770_decreased_survivor_rate | 0.42110251 |
| 170 | MP0001943_abnormal_respiration | 0.40091795 |
| 171 | MP0005248_abnormal_Harderian_gland | 0.39254485 |
| 172 | MP0000733_abnormal_muscle_development | 0.38890852 |
| 173 | MP0002063_abnormal_learning/memory/cond | 0.38806095 |
| 174 | MP0001849_ear_inflammation | 0.37768394 |
| 175 | MP0005508_abnormal_skeleton_morphology | 0.36923011 |
| 176 | MP0004885_abnormal_endolymph | 0.35790389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Termporal pattern (HP:0011008) | 8.58077866 |
| 2 | * Insidious onset (HP:0003587) | 8.58077866 |
| 3 | Abnormality of the vocal cords (HP:0008777) | 7.64117454 |
| 4 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 7.38536714 |
| 5 | * Increased CSF protein (HP:0002922) | 7.36097369 |
| 6 | * Action tremor (HP:0002345) | 6.57341110 |
| 7 | * Onion bulb formation (HP:0003383) | 6.55192636 |
| 8 | * Steppage gait (HP:0003376) | 6.21984150 |
| 9 | Deep venous thrombosis (HP:0002625) | 5.93775877 |
| 10 | * Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 5.91033699 |
| 11 | * Hammertoe (HP:0001765) | 5.71359036 |
| 12 | * Foot dorsiflexor weakness (HP:0009027) | 5.30929185 |
| 13 | * Peripheral demyelination (HP:0011096) | 5.10915372 |
| 14 | * Abnormality of the foot musculature (HP:0001436) | 4.89643817 |
| 15 | * Decreased motor nerve conduction velocity (HP:0003431) | 4.89432310 |
| 16 | Complement deficiency (HP:0004431) | 4.85164572 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 4.82285263 |
| 18 | Glomerulonephritis (HP:0000099) | 4.38378444 |
| 19 | Abnormality of complement system (HP:0005339) | 4.19768644 |
| 20 | White forelock (HP:0002211) | 4.12931767 |
| 21 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.05125378 |
| 22 | * Postural tremor (HP:0002174) | 3.71061503 |
| 23 | Hemorrhage of the eye (HP:0011885) | 3.46410948 |
| 24 | Choroideremia (HP:0001139) | 3.45603252 |
| 25 | Joint hemorrhage (HP:0005261) | 3.45485658 |
| 26 | Hypopigmentation of the fundus (HP:0007894) | 3.42663865 |
| 27 | Patchy hypopigmentation of hair (HP:0011365) | 3.37027318 |
| 28 | Epiphyseal dysplasia (HP:0002656) | 3.31844934 |
| 29 | Hypomagnesemia (HP:0002917) | 3.26417419 |
| 30 | Orchitis (HP:0100796) | 3.22718291 |
| 31 | Atrophic scars (HP:0001075) | 3.19451367 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.18134853 |
| 33 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.09099083 |
| 34 | * Distal sensory impairment (HP:0002936) | 3.06164762 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.05260645 |
| 36 | Amyloidosis (HP:0011034) | 3.04566390 |
| 37 | Abnormal sex determination (HP:0012244) | 3.03530379 |
| 38 | Sex reversal (HP:0012245) | 3.03530379 |
| 39 | Blue irides (HP:0000635) | 3.01104431 |
| 40 | Myositis (HP:0100614) | 2.97765241 |
| 41 | Absent epiphyses (HP:0010577) | 2.97187398 |
| 42 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.97187398 |
| 43 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.96573526 |
| 44 | Purpura (HP:0000979) | 2.95892678 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.95851419 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.95816823 |
| 47 | Optic neuritis (HP:0100653) | 2.95816823 |
| 48 | Prolonged partial thromboplastin time (HP:0003645) | 2.85963597 |
| 49 | Abnormality of magnesium homeostasis (HP:0004921) | 2.77245103 |
| 50 | Alacrima (HP:0000522) | 2.71784506 |
| 51 | Xanthomatosis (HP:0000991) | 2.67246451 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.63702828 |
| 53 | Fragile skin (HP:0001030) | 2.61168524 |
| 54 | Hypercholesterolemia (HP:0003124) | 2.53252272 |
| 55 | Polycythemia (HP:0001901) | 2.52866797 |
| 56 | Hypoplasia of the uterus (HP:0000013) | 2.49306540 |
| 57 | Flat acetabular roof (HP:0003180) | 2.47477507 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.45837432 |
| 59 | Heterochromia iridis (HP:0001100) | 2.43250674 |
| 60 | Small epiphyses (HP:0010585) | 2.40603476 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37407098 |
| 62 | Obstructive lung disease (HP:0006536) | 2.37407098 |
| 63 | Gingival bleeding (HP:0000225) | 2.35194566 |
| 64 | Difficulty walking (HP:0002355) | 2.34578699 |
| 65 | Decreased central vision (HP:0007663) | 2.33611113 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.33419674 |
| 67 | Abnormal auditory evoked potentials (HP:0006958) | 2.32858614 |
| 68 | Hypobetalipoproteinemia (HP:0003563) | 2.29944657 |
| 69 | Supernumerary ribs (HP:0005815) | 2.28930587 |
| 70 | Nephritis (HP:0000123) | 2.25932202 |
| 71 | Abnormality of the peritoneum (HP:0002585) | 2.25585552 |
| 72 | * Kyphoscoliosis (HP:0002751) | 2.21176007 |
| 73 | Menorrhagia (HP:0000132) | 2.19198571 |
| 74 | Spastic paraparesis (HP:0002313) | 2.19146398 |
| 75 | Abnormal ossification of hand bones (HP:0005921) | 2.18964596 |
| 76 | Myocardial infarction (HP:0001658) | 2.18313011 |
| 77 | Attenuation of retinal blood vessels (HP:0007843) | 2.15058808 |
| 78 | Abnormality of carpal bone ossification (HP:0006257) | 2.14832090 |
| 79 | Protrusio acetabuli (HP:0003179) | 2.14614049 |
| 80 | Pulmonary embolism (HP:0002204) | 2.11962174 |
| 81 | Hand muscle atrophy (HP:0009130) | 2.09503979 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.09431529 |
| 83 | Bladder diverticulum (HP:0000015) | 2.08832977 |
| 84 | Scotoma (HP:0000575) | 2.07311280 |
| 85 | Biconcave vertebral bodies (HP:0004586) | 2.05266813 |
| 86 | Decreased lacrimation (HP:0000633) | 2.01825037 |
| 87 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.01662145 |
| 88 | Diaphragmatic weakness (HP:0009113) | 2.00902915 |
| 89 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.00256283 |
| 90 | * Ulnar claw (HP:0001178) | 17.2593591 |
| 91 | * Segmental peripheral demyelination/remyelination (HP:0003481) | 13.9787343 |
| 92 | * Impaired proprioception (HP:0010831) | 10.6868512 |
| 93 | Abnormal hand bone ossification (HP:0010660) | 1.99802399 |
| 94 | Ankle contracture (HP:0006466) | 1.99491937 |
| 95 | Ocular albinism (HP:0001107) | 1.98253082 |
| 96 | Prolonged bleeding time (HP:0003010) | 1.96006890 |
| 97 | Thrombophlebitis (HP:0004418) | 1.95127787 |
| 98 | Colitis (HP:0002583) | 1.92287722 |
| 99 | Abnormality of the lumbar spine (HP:0100712) | 1.90307916 |
| 100 | Stridor (HP:0010307) | 1.88945245 |
| 101 | Upper limb amyotrophy (HP:0009129) | 1.88747874 |
| 102 | Distal upper limb amyotrophy (HP:0007149) | 1.88747874 |
| 103 | Cerebral aneurysm (HP:0004944) | 1.88588807 |
| 104 | Arterial thrombosis (HP:0004420) | 1.87813833 |
| 105 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.86872624 |
| 106 | Osteomalacia (HP:0002749) | 1.86520940 |
| 107 | Increased IgE level (HP:0003212) | 1.85616436 |
| 108 | Germ cell neoplasia (HP:0100728) | 1.85537885 |
| 109 | Epistaxis (HP:0000421) | 1.85494540 |
| 110 | Spontaneous abortion (HP:0005268) | 1.84841552 |
| 111 | Coxa vara (HP:0002812) | 1.84286661 |
| 112 | Hypolipoproteinemia (HP:0010981) | 1.83254442 |
| 113 | Mediastinal lymphadenopathy (HP:0100721) | 1.81395263 |
| 114 | * Peripheral hypomyelination (HP:0007182) | 1.81340098 |
| 115 | Gingivitis (HP:0000230) | 1.80430557 |
| 116 | Spontaneous hematomas (HP:0007420) | 1.78728338 |
| 117 | Premature graying of hair (HP:0002216) | 1.78336043 |
| 118 | Abnormal gallbladder physiology (HP:0012438) | 1.77300344 |
| 119 | Cholecystitis (HP:0001082) | 1.77300344 |
| 120 | Hypoalphalipoproteinemia (HP:0003233) | 1.75645555 |
| 121 | Disproportionate tall stature (HP:0001519) | 1.75322209 |
| 122 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.75020021 |
| 123 | Seborrheic dermatitis (HP:0001051) | 1.73976356 |
| 124 | Keratoconjunctivitis (HP:0001096) | 1.73816656 |
| 125 | Episodic fever (HP:0001954) | 1.69774760 |
| 126 | Aortic dissection (HP:0002647) | 1.69275501 |
| 127 | Abnormality of the fovea (HP:0000493) | 1.69210703 |
| 128 | Glomerulopathy (HP:0100820) | 1.69083929 |
| 129 | Soft skin (HP:0000977) | 1.69039569 |
| 130 | Macular degeneration (HP:0000608) | 1.68589134 |
| 131 | Hypercalciuria (HP:0002150) | 1.67947425 |
| 132 | Alopecia of scalp (HP:0002293) | 1.66520244 |
| 133 | * Slow progression (HP:0003677) | 1.63393178 |
| 134 | Renovascular hypertension (HP:0100817) | 1.63178906 |
| 135 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.59904646 |
| 136 | Mitral valve prolapse (HP:0001634) | 1.58599341 |
| 137 | Childhood onset (HP:0011463) | 1.54867191 |
| 138 | Bowel diverticulosis (HP:0005222) | 1.46469962 |
| 139 | * Upper limb muscle weakness (HP:0003484) | 1.46221202 |
| 140 | Peritonitis (HP:0002586) | 1.44357405 |
| 141 | Ankle clonus (HP:0011448) | 1.43913171 |
| 142 | * Pes cavus (HP:0001761) | 1.43773116 |
| 143 | Gonadal dysgenesis (HP:0000133) | 1.40323023 |
| 144 | Pheochromocytoma (HP:0002666) | 1.39688084 |
| 145 | Abnormality of the lower motor neuron (HP:0002366) | 1.39148428 |
| 146 | Myokymia (HP:0002411) | 1.38561692 |
| 147 | Hypoventilation (HP:0002791) | 1.38110066 |
| 148 | Axonal loss (HP:0003447) | 1.35800099 |
| 149 | Dilatation of the ascending aorta (HP:0005111) | 1.29256069 |
| 150 | Striae distensae (HP:0001065) | 1.28776991 |
| 151 | Hyporeflexia of lower limbs (HP:0002600) | 1.28383863 |
| 152 | Genu recurvatum (HP:0002816) | 1.24209480 |
| 153 | Overgrowth (HP:0001548) | 1.23739281 |
| 154 | Aplasia cutis congenita (HP:0001057) | 1.23450796 |
| 155 | Increased connective tissue (HP:0009025) | 1.20355972 |
| 156 | Increased variability in muscle fiber diameter (HP:0003557) | 1.18865896 |
| 157 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.17846089 |
| 158 | Osteolytic defects of the hand bones (HP:0009699) | 1.17846089 |
| 159 | Increased corneal curvature (HP:0100692) | 1.14194236 |
| 160 | Keratoconus (HP:0000563) | 1.14194236 |
| 161 | Myotonia (HP:0002486) | 1.13402160 |
| 162 | Difficulty running (HP:0009046) | 1.13327576 |
| 163 | Supranuclear gaze palsy (HP:0000605) | 1.13169718 |
| 164 | Neuroendocrine neoplasm (HP:0100634) | 1.12698716 |
| 165 | Muscular dystrophy (HP:0003560) | 1.12284554 |
| 166 | Hypercortisolism (HP:0001578) | 1.11867019 |
| 167 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.11779314 |
| 168 | Hypoplasia of the brainstem (HP:0002365) | 1.11779314 |
| 169 | Hyperextensible skin (HP:0000974) | 1.10330670 |
| 170 | Submucous cleft hard palate (HP:0000176) | 1.08828738 |
| 171 | Wrist flexion contracture (HP:0001239) | 1.06950277 |
| 172 | Thoracolumbar scoliosis (HP:0002944) | 1.06535609 |
| 173 | Muscle fiber splitting (HP:0003555) | 1.04118913 |
| 174 | Abnormality of pain sensation (HP:0010832) | 1.04030654 |
| 175 | Impaired pain sensation (HP:0007328) | 1.04030654 |
| 176 | Esophageal atresia (HP:0002032) | 1.02110176 |
| 177 | Broad metatarsal (HP:0001783) | 1.00929328 |
| 178 | Insomnia (HP:0100785) | 1.00627020 |
| 179 | Split hand (HP:0001171) | 0.99963466 |
| 180 | Venous insufficiency (HP:0005293) | 0.99595283 |
| 181 | Neonatal short-limb short stature (HP:0008921) | 0.99556363 |
| 182 | Distal arthrogryposis (HP:0005684) | 0.98784940 |
| 183 | Milia (HP:0001056) | 0.98776080 |
| 184 | Spinal rigidity (HP:0003306) | 0.98505474 |
| 185 | Abnormality of skeletal muscle fiber size (HP:0012084) | 0.98135749 |
| 186 | Wormian bones (HP:0002645) | 0.97843058 |
| 187 | Nephrolithiasis (HP:0000787) | 0.96839107 |
| 188 | Infantile muscular hypotonia (HP:0008947) | 0.95282538 |
| 189 | Hypoplasia of the iris (HP:0007676) | 0.94602315 |
| 190 | Difficulty climbing stairs (HP:0003551) | 0.93393896 |
| 191 | Gastrointestinal infarctions (HP:0005244) | 0.92824260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK2 | 4.89321473 |
| 2 | IRAK1 | 3.54347728 |
| 3 | FGFR4 | 3.47669944 |
| 4 | KSR2 | 3.46673564 |
| 5 | ERN1 | 3.44272673 |
| 6 | STK39 | 3.27135941 |
| 7 | RET | 3.22098639 |
| 8 | LMTK2 | 3.17485528 |
| 9 | MAP3K2 | 3.01876463 |
| 10 | EPHB1 | 2.96148892 |
| 11 | WNK4 | 2.72853179 |
| 12 | NTRK1 | 2.58474245 |
| 13 | UHMK1 | 2.48416400 |
| 14 | CDK12 | 2.44532536 |
| 15 | LIMK1 | 2.37485333 |
| 16 | PRKD3 | 2.30196588 |
| 17 | MAP4K1 | 2.22695312 |
| 18 | NTRK3 | 2.21791428 |
| 19 | SIK2 | 2.03428130 |
| 20 | WNK1 | 1.99841475 |
| 21 | BLK | 1.95835609 |
| 22 | MINK1 | 1.95088199 |
| 23 | TRIB3 | 1.93534934 |
| 24 | MARK2 | 1.87929621 |
| 25 | LATS2 | 1.86898005 |
| 26 | EEF2K | 1.82773249 |
| 27 | MAP3K9 | 1.79712670 |
| 28 | MAP2K3 | 1.75723711 |
| 29 | TYK2 | 1.63955766 |
| 30 | ICK | 1.62269870 |
| 31 | PRPF4B | 1.56983670 |
| 32 | PAK6 | 1.56068710 |
| 33 | IRAK4 | 1.48804913 |
| 34 | ERBB2 | 1.40401188 |
| 35 | PHKG1 | 1.39484897 |
| 36 | PHKG2 | 1.39484897 |
| 37 | TGFBR2 | 1.38706457 |
| 38 | MAP3K4 | 1.37525844 |
| 39 | FGR | 1.31424915 |
| 40 | IRAK3 | 1.23938169 |
| 41 | ZAP70 | 1.21886725 |
| 42 | PTK6 | 1.20934838 |
| 43 | LRRK2 | 1.20056420 |
| 44 | PTK2B | 1.16463243 |
| 45 | PTK2 | 1.16455124 |
| 46 | SMG1 | 1.14946932 |
| 47 | MAP2K1 | 1.12053025 |
| 48 | PKN2 | 1.10071805 |
| 49 | CDK5 | 1.08238358 |
| 50 | FES | 1.06672243 |
| 51 | RIPK4 | 1.03059439 |
| 52 | MATK | 1.02592346 |
| 53 | JAK3 | 1.01766271 |
| 54 | BTK | 1.00635871 |
| 55 | HCK | 1.00257847 |
| 56 | MAP3K1 | 1.00073322 |
| 57 | MAP3K6 | 0.99657757 |
| 58 | SYK | 0.98361644 |
| 59 | CAMK1G | 0.94222703 |
| 60 | FER | 0.94121815 |
| 61 | TTN | 0.92857543 |
| 62 | CAMK1D | 0.92741318 |
| 63 | DDR2 | 0.92346273 |
| 64 | SCYL2 | 0.91561848 |
| 65 | RPS6KA2 | 0.88027656 |
| 66 | MET | 0.87258555 |
| 67 | MAP2K2 | 0.83249415 |
| 68 | ROCK1 | 0.82999213 |
| 69 | MAP3K3 | 0.80123050 |
| 70 | SGK3 | 0.79876102 |
| 71 | TNK2 | 0.79734078 |
| 72 | PDGFRA | 0.79730298 |
| 73 | SIK1 | 0.78629988 |
| 74 | SGK223 | 0.78338033 |
| 75 | SGK494 | 0.78338033 |
| 76 | MAP3K14 | 0.77112209 |
| 77 | AKT3 | 0.76023031 |
| 78 | FRK | 0.75378151 |
| 79 | PRKD2 | 0.75269936 |
| 80 | PRKAA2 | 0.74505277 |
| 81 | MAP2K4 | 0.73643011 |
| 82 | ROCK2 | 0.72001459 |
| 83 | FYN | 0.71491576 |
| 84 | TBK1 | 0.68491318 |
| 85 | PAK3 | 0.66924629 |
| 86 | CSF1R | 0.66126934 |
| 87 | TESK2 | 0.65940537 |
| 88 | BRD4 | 0.64990509 |
| 89 | MARK3 | 0.64438983 |
| 90 | GSK3A | 0.63944899 |
| 91 | LYN | 0.63433278 |
| 92 | CAMKK1 | 0.62633935 |
| 93 | MAP3K7 | 0.62142729 |
| 94 | PRKD1 | 0.62114200 |
| 95 | EPHB2 | 0.61623840 |
| 96 | PLK2 | 0.61385703 |
| 97 | MTOR | 0.60643286 |
| 98 | LCK | 0.60217239 |
| 99 | PIK3CG | 0.59418269 |
| 100 | SRC | 0.59186564 |
| 101 | MAPK11 | 0.58789900 |
| 102 | PAK4 | 0.58774218 |
| 103 | GRK6 | 0.57660684 |
| 104 | MARK1 | 0.56198782 |
| 105 | BMX | 0.56043850 |
| 106 | RPS6KC1 | 0.56020675 |
| 107 | RPS6KL1 | 0.56020675 |
| 108 | KIT | 0.54866494 |
| 109 | MAPK12 | 0.54783698 |
| 110 | SGK2 | 0.54285531 |
| 111 | TAOK2 | 0.54139869 |
| 112 | DYRK1B | 0.53664734 |
| 113 | ITK | 0.51534926 |
| 114 | ILK | 0.50601591 |
| 115 | PDGFRB | 0.49392028 |
| 116 | CDC42BPA | 0.49364761 |
| 117 | CDK14 | 0.49070507 |
| 118 | TYRO3 | 0.48178527 |
| 119 | MAP3K11 | 0.47650772 |
| 120 | PRKCH | 0.47258579 |
| 121 | CDK6 | 0.44707391 |
| 122 | RPS6KA6 | 0.42697851 |
| 123 | YES1 | 0.42663242 |
| 124 | JAK2 | 0.41687537 |
| 125 | SGK1 | 0.41311267 |
| 126 | CDK7 | 0.41092264 |
| 127 | MAPK3 | 0.40956152 |
| 128 | PDK1 | 0.40299358 |
| 129 | ADRBK1 | 0.40100791 |
| 130 | RPS6KA1 | 0.39341478 |
| 131 | PDPK1 | 0.38894735 |
| 132 | NEK2 | 0.37665448 |
| 133 | FGFR3 | 0.36869565 |
| 134 | JAK1 | 0.35657648 |
| 135 | FGFR2 | 0.35178945 |
| 136 | HIPK2 | 0.34961034 |
| 137 | KSR1 | 0.34439647 |
| 138 | EPHA3 | 0.32816709 |
| 139 | RIPK1 | 0.32766580 |
| 140 | GRK5 | 0.31996310 |
| 141 | PRKCQ | 0.31629881 |
| 142 | PINK1 | 0.30210554 |
| 143 | CDK15 | 0.29650745 |
| 144 | INSR | 0.29227074 |
| 145 | MAPK10 | 0.27747373 |
| 146 | NEK9 | 0.27393116 |
| 147 | CSNK1G2 | 0.27253557 |
| 148 | CDK18 | 0.26766121 |
| 149 | LATS1 | 0.26675669 |
| 150 | CSK | 0.26552008 |
| 151 | PRKCZ | 0.26299510 |
| 152 | MAP3K8 | 0.25969063 |
| 153 | PRKCE | 0.25647177 |
| 154 | STK38 | 0.25519284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.28171548 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.68824181 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.16284185 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.04629156 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.77640132 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62663750 |
| 7 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.44866705 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.19820497 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.19549540 |
| 10 | Axon guidance_Homo sapiens_hsa04360 | 1.99100577 |
| 11 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.94298705 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93263002 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.84070932 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81074646 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.78542674 |
| 16 | Glioma_Homo sapiens_hsa05214 | 1.76591183 |
| 17 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.75846146 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.74135269 |
| 19 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.73861661 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73378219 |
| 21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.72580470 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.72528712 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70242036 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.70182712 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.69365495 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69238871 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.68350372 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.63685761 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63309369 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61695193 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61643048 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.55413932 |
| 33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.53776879 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.51423240 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.51196382 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.49548023 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.46347906 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.42896536 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.42263944 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.40131699 |
| 41 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.37013833 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.37011383 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32166745 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31560100 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24951140 |
| 46 | Endometrial cancer_Homo sapiens_hsa05213 | 1.23609617 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.22192718 |
| 48 | Long-term depression_Homo sapiens_hsa04730 | 1.18750446 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17492589 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16010570 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14825739 |
| 52 | Malaria_Homo sapiens_hsa05144 | 1.14522772 |
| 53 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.14505748 |
| 54 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10659618 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10080811 |
| 56 | Gap junction_Homo sapiens_hsa04540 | 1.09220437 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08350156 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07904873 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.07383776 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04815279 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04767906 |
| 62 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.04470838 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 1.04325047 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01321875 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01153293 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01032544 |
| 67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99935497 |
| 68 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.98863626 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.98577139 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98054728 |
| 71 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97267421 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97134655 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94645392 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.94369041 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.93679657 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.93424172 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92663115 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.92375742 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.89549480 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89330889 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88751238 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88291956 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.88274635 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85774020 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85635833 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.84236891 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.83264375 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83131619 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.82758279 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82191563 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82105515 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81331907 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.81137714 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.79105710 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78296972 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78284386 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77017927 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.76742753 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76200002 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.76131970 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74846253 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74239246 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73734630 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.72182869 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.71368572 |
| 106 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71006383 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70277578 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68707380 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68037315 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67644818 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67480349 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67253308 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66783495 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66703983 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.66659633 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66378996 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.66378844 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65638183 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65630953 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.64562020 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63079519 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.62713349 |
| 123 | Hepatitis B_Homo sapiens_hsa05161 | 0.62468401 |
| 124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61355490 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.61136288 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.61062668 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60484460 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59928384 |
| 129 | Adherens junction_Homo sapiens_hsa04520 | 0.59291183 |
| 130 | Legionellosis_Homo sapiens_hsa05134 | 0.59232553 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58375297 |
| 132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58203759 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.57841340 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57342332 |
| 135 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56873867 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55995798 |
| 137 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55028470 |
| 138 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54748480 |
| 139 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53642550 |
| 140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52453071 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52434701 |
| 142 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52220921 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51599863 |
| 144 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51578428 |
| 145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51264667 |
| 146 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50472990 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50230461 |
| 148 | Alcoholism_Homo sapiens_hsa05034 | 0.49049350 |
| 149 | Endocytosis_Homo sapiens_hsa04144 | 0.48767216 |
| 150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47976374 |
| 151 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47500764 |
| 152 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46881051 |
| 153 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46766893 |
| 154 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46569910 |
| 155 | Lysine degradation_Homo sapiens_hsa00310 | 0.45368922 |
| 156 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44965732 |
| 157 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.43880087 |
| 158 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43553561 |
| 159 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41795972 |
| 160 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41693026 |
| 161 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40706845 |
| 162 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40236192 |
| 163 | Apoptosis_Homo sapiens_hsa04210 | 0.39751341 |
| 164 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38273322 |
| 165 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35343688 |

